Pacira BioSciences Inc (NASDAQ: PCRX) stock closed at $19.09 on 12/4/24 after a major increase of 14.4%. Moreover, exceptionally high trading volume at 267% of normal accompanied the advance. The stock has risen 9.6% during the last week but has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Pacira BioSciences has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Pacira BioSciences has a very high Appreciation Score of 87 but a very low Power Rating of 12, and the Neutral Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment